Auer小体对初诊非M3型急性髓细胞白血病患者预后的影响

黄雅睿; 黄兴琴; 黄祥涛; 罗承昕; 徐双年; 陈洁平

doi:10.16016/j.2097-0927.202106069

您当前的位置：

首页 >

文章列表页 >

Auer小体对初诊非M3型急性髓细胞白血病患者预后的影响

临床医学 | 更新时间：2026-01-09

- Auer小体对初诊非M3型急性髓细胞白血病患者预后的影响
- Effects of Auer rod on prognosis in patients with freshly-diagnosed non-M3 type acute myeloid leukemia
- 陆军军医大学学报 2022年44卷第3期页码：224-230
- 作者机构：
  
  400038 重庆，陆军军医大学(第三军医大学)第一附属医院血液病中心
- 作者简介：
  
  [ 陈洁平，E-mail：chenjpxn@163.com CHEN Jieping, E-mail: chenjpxn@163.com
- 基金信息：
  
  国家自然科学基金青年科学基金(81800172)
- DOI：10.16016/j.2097-0927.202106069
  中图分类号： R557
- 收稿：2021-06-08，
  
  修回：2021-08-10，
  
  纸质出版：2022-02-15
- 稿件说明：
移动端阅览
黄雅睿, 黄兴琴, 黄祥涛, 等. Auer小体对初诊非M3型急性髓细胞白血病患者预后的影响[J]. 陆军军医大学学报, 2022,44(3):224-230.

Yarui HUANG, Xingqin HUANG, Xiangtao HUANG, et al. Effects of Auer rod on prognosis in patients with freshly-diagnosed non-M3 type acute myeloid leukemia[J]. Journal of Army Medical University, 2022, 44(3): 224-230.
黄雅睿, 黄兴琴, 黄祥涛, 等. Auer小体对初诊非M3型急性髓细胞白血病患者预后的影响[J]. 陆军军医大学学报, 2022,44(3):224-230. DOI： 10.16016/j.2097-0927.202106069.

Yarui HUANG, Xingqin HUANG, Xiangtao HUANG, et al. Effects of Auer rod on prognosis in patients with freshly-diagnosed non-M3 type acute myeloid leukemia[J]. Journal of Army Medical University, 2022, 44(3): 224-230. DOI： 10.16016/j.2097-0927.202106069.

摘要

目的

探究Auer小体对初诊非M3型急性髓系白血病(acute myeloid leukemia，AML)预后的影响。

方法

采用回顾性队列研究设计，纳入本中心2012年1月至2019年12月收治的154例初诊非M3型AML患者病历资料，根据骨髓原始细胞有无Auer小体分为Auer小体阳性组和Auer小体阴性组，随访数据通过电子病历或打电话获取，比较两组患者临床资料的差异，包括性别、年龄、白细胞(white blood cell，WBC)计数、血小板(platelet，PLT)计数、血红蛋白(hemoglobin，Hb)、乳酸脱氢酶(lactate dehydrogenase，LDH)、法美英协作组(French-American-British，FAB)分型、骨髓原始细胞比例及危险度分层等；通过Kaplan-Meier法和COX多因素回归模型比较两组时间事件结局的差异。

结果

与Auer小体阴性组AML患者相比，阳性组在FAB分型中的M2型比例较高、M5型比例较低(

0.001，

=0.005)，且骨髓原始细胞比例显著降低(

0.001)、

WT1

基因突变频率明显增高(

=0.006)，病死率显著降低(

=0.008)。生存分析结果显示

，阳性组患者总生存率(overall survival，OS)高于阴性组(

=0.010)。多因素COX回归分析表明，Auer小体是OS的独立影响因素(

=0.298，95%

: 0.104~0.853，

=0.024)。

结论

Auer小体是影响AML的独立预后因素，对AML的预后具有较好的预测价值。

Abstract

Objective

To investigate the effects of Auer rod on the prognosis of newly-diagnosed non-M3 type acute myeloid leukemia (AML).

Methods

A retrospective cohort study was performed on 154 patients initially diagnosed as non-M3 type AML in our center from January 2012 to December 2019. According to the presence or absence of Auer rod in the bone marrow blasts

the patients were divided into Auer rod positive and negative groups. Their follow-up data were obtained from medical records and through telephone conversations with the enrolled patients. Clinical data were compared between the 2 groups

including gender

age

white blood cell (WBC) count

platelet (PLT) count

hemoglobin (Hb)

lactate dehydrogenase (LDH)

French-American-British (FAB) classification

percentage of blast cells in bone marrow

and cytogenetic risk stratification. Kaplan-Meier survival analysis and multivariate COX regression model were used to analyze the difference in outcome of time-events between the 2 groups.

Results

As compared with the Auer rod negative group

the Auer rod positive group had higher proportion of M2 type (

0.001) but lower proportion of M5 type (

=0.005) in FAB classification

lower percentage of bone marrow blasts (

0.001)

higher mutation frequency of

WT1

gene (

=0.006)

and lower mortality rate (

=0.008). The overall survival (OS) was significantly longer in the Auer rod positive group than the negative group (

=0.01). Multivariate COX regression analysis showed that Aue

r rod was an independent influencing factor for OS (

=0.298

95%

: 0.104~0.853

=0.024).

Conclusion

Auer rod is an independent prognostic factor of AML

and presents good prognostic value.

关键词

Keywords

references

FORAN J M. New prognostic markers in acute myeloid leukemia: perspective from the clinic[J]. Hematol Am Soc Hematol Educ Program, 2010, 2010: 47-55. DOI: 10.1182/asheducation-2010.1.47.

KELLAWAY S, CHIN P S, BARNEH F, et al . T(8;21) acute myeloid leukemia as a paradigm for the understanding of leukemogenesis at the level of gene regulation and chromatin programming[J ] . Cells, 2020, 9(12): 2681. DOI: 10.3390/cells9122681.

DÖHNER H, WEISDORF D J, BLOOMFIELD C D. Acute myeloid leukemia[J]. N Engl J Med, 2015, 373(12): 1136-1152. DOI: 10.1056/nejmra1406184.

LIU L, CHEN R, ZHANG Y, et al . Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia[J ] . Diagn Pathol, 2015, 10: 109. DOI: 10.1186/s13000-015-0345-6.

HUANG H, QIN T, XU Z, et al . Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia[J ] . Br J Haematol, 2020, 188(5): 796-800. DOI: 10.1111/bjh.16326.

GUPTA A, REDDY G K, NALLA N, et al . Lymphoblasts with Auer rod-like inclusions in a case of paediatric B lymphoblastic leukemia[J ] . Pediatr Blood Cancer, 2017, 64(7): e26392. DOI: 10.1002/pbc.26392.

KRIS M G, MERTELSMANN R, JHANWAR S, et al . Relationship of auer rods and chromosome findings to outcome in eighty-nine adults with acute nonlymphoblastic leukemia[J ] . Leuk Res, 1985, 9(10): 1231-1235. DOI: 10.1016/0145-2126(85)90150-X.

MERTELSMANN R, TZVI THALER H, TO L, et al . Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia[J ] . Blood, 1980, 56(5): 773-781.

RITTER J, VORMOOR J, CREUTZIG U, et al . Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -83[J ] . Med Pediatr Oncol, 1989, 17(3): 202-209. DOI: 10.1002/mpo.2950170307.

VARDIMAN J W, THIELE J, ARBER D A, et al . The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes[J ] . Blood, 2009, 114(5): 937-951. DOI: 10.1182/blood-2009-03-209262.

DÖHNER H, ESTEY E H, AMADORI S, et al . Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European Leukemia Net[J ] . Blood, 2010, 115(3): 453-474. DOI: 10.1182/blood-2009-07-235358.

张之南. 血液病诊断及疗效标准[M]. 第2版. 天津: 天津科学技术出版社, 1998: 171-183.

ZHANG Z N. Criteria for diagnosis and curative effect of hematological diseases[M]. 2nd ed. Tianjin: Tianjin Science and Technology Press, 1998: 171-183.

NARAYANAN D, WEINBERG O K. How I investigate acute myeloid leukemia[J]. Int J Lab Hematol, 2020, 42(1): 3-15. DOI: 10.1111/ijlh.13135.

VAGO L, GOJO I. Immune escape and immunotherapy of acute myeloid leukemia[J]. J Clin Invest, 2020, 130(4): 1552-1564. DOI: 10.1172/jci129204.

HASSAN H T, REES J K. Auer bodies in acute myeloid leukaemia patients[J]. Pathol Res Pract, 1990, 186(2): 293-295. DOI: 10.1016/s0344-0338(11)80547-9.

BILLSTRÖM R, NILSSON P G, MITELMAN F. Characteristic patterns of chromosome abnormalities in acute myeloid leukemia with Auer rods[J]. Cancer Genet Cytogenet, 1987, 28(2): 191-199. DOI: 10.1016/0165-4608(87)90205-6.

姜艳红, 焦扬, 陈光意, 等. Auer小体阳性与阴性初治非AML-M3型原发急性髓系白血病临床特点对比分析[J]. 广东医学, 2020, 41(7): 702-707. DOI: 10.13820/j.cnki.gdyx.20192056.

JIANG Y H, JIAO Y, CHEN G Y, et al . Comparative analysis of clinical characteristics between Auer body positive and negative de novo primary acute myeloid leukemia patients (non-AML-M3 type)[J ] . Guangdong Med J, 2020, 41(7): 702-707. D OI: 10.13820/j.cnki.gdyx.20192056.

ZITTOUN R, CADIOU M, BAYLE C, et al . Prognostic value of cytologic parameters in acute myelogenous leukemia[J ] . Cancer, 1984, 53(7): 1526-1532. DOI: 10.1002/1097-0142(19840401)53:71526:aid-cncr2820530718 > 3.0.co;2-2.

STASS S A, LANHAM G R, BUTLER D, et al . Auer rods in mature granulocytes: a unique morphologic feature of acute myelogenous leukemia with maturation[J ] . Am J Clin Pathol, 1984, 81(5): 662-665. DOI: 10.1093/ajcp/81.5.662.

贾红芳, 马瑞玲, 高艳, 等. Auer小体在AML诊断中的价值[J]. 临床医药实践, 2004, 13(12): 902-903. DOI: 10.3969/j.issn.1671-8631.2004.12.008.

JIA H F, MA R L, GAO Y, et al . Value of Auer rod in the diagnosis of acute myeloid leukemia[J ] . Proceeding Clin Med, 2004, 13(12): 902-903. DOI: 10.3969/j.issn.1671-8631.2004.12.008.

杨云霞, 林雅萍, 熊树民. Auer小体在诊断ANLL中的价值──附255例分析. 上海医学检验杂志. 1998, 13(1): 40-41.

YANG Y X, LIN Y P, XIONG S M. The value of Auer corpuscle in the diagnosis of ANLL: an analysis of 255 cases[J]. Shanghai J Med Lab Sci, 1998, 13(1): 40-41.

YANADA M, TERAKURA S, YOKOZAWA T, et al . Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia[J ] . Leuk Lymphoma, 2004, 45(9): 1803-1808. DOI: 10.1080/10428190410001693551.

LUO S, YU K, YAN Q X, et al . Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 in de novo non-M3 acute myeloid leukemia[J ] . Leuk Lymphoma, 2014, 55(2): 349-357. DOI: 10.3109/10428194.2013.791985.

胡忠利, 黄保军, 潘少君. WT1高表达及CD34 + 和Auer + 与急性髓细胞性白血病患者预后的关系[J ] . 中国实验血液学杂志, 2016, 24(6): 1670-1674. DOI: 10.7534/j.issn.1009-2137.2016.06.011..

HU Z L, HUANG B J, PAN S J. Effect of WT1 gene high expression and CD34 + and auer + on prognosis of acute myeloid leukemia[J ] . J Exp Hematol, 2016, 24(6): 1670-1674. DOI: 10.7534/j.issn.1009-2137.2016.06.011..

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

核仁磷酸蛋白1突变的分子异质性对急性髓系白血病预后的影响

EVI1基因阳性的急性髓系白血病患者临床特点及其造血干细胞移植的疗效观察

血清uPA蛋白水平与急性髓系白血病的预后有关

基于中国人群的雌激素受体表达新分层（低/中/高）可更精准地预测HR⁺/HER2^-早期乳腺癌患者的预后

转录因子TGIF1高表达胃癌的免疫抑制性微环境特征及临床意义分析